Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach
Abstract Using successful genome-wide association results in psychiatry for drug repurposing is an ongoing challenge. Databases collecting drug targets and gene annotations are growing and can be harnessed to shed a new light on psychiatric disorders. We used genome-wide association study (GWAS) sum...
Enregistré dans:
Auteurs principaux: | H. A. Gaspar, G. Breen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4fb5cf2ef0a5453dba3fd3a890202636 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci
par: Atsushi Takata, et autres
Publié: (2017) -
Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia
par: V. Bansal, et autres
Publié: (2018) -
Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet
par: Hua Yu, et autres
Publié: (2021) -
Genome wide association for addiction: replicated results and comparisons of two analytic approaches.
par: Tomas Drgon, et autres
Publié: (2010) -
Targeted genome-wide enrichment of functional regions.
par: Periannan Senapathy, et autres
Publié: (2010)